Ignite Creation Date:
2025-12-24 @ 3:05 PM
Ignite Modification Date:
2026-01-31 @ 2:31 AM
Study NCT ID:
NCT01884259
Status:
COMPLETED
Last Update Posted:
2022-05-26
First Post:
2012-05-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN
Sponsor:
Arbeitsgemeinschaft medikamentoese Tumortherapie
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AGMT_HNO 2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None